Екцем (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Екцем" in Serbian language version.

refsWebsite

Global rank Serbian rank

4^th place

8^th place

2^nd place

4^th place

3^rd place

2^nd place

low place

102^nd place

266^th place

books.google.com

Ring, Johannes; Przybilla, Bernhard; Ruzicka, Thomas (2006). Handbook of atopic eczema. Birkhäuser. стр. 4. ISBN 978-3-540-23133-2. Приступљено 28. 4. 2015.

Bershad, SV (1. 11. 2011). „In the clinic. Atopic dermatitis (eczema)”. Annals of Internal Medicine. 155 (9): ITC51—15; quiz ITC516. PMID 22041966. doi:10.7326/0003-4819-155-9-201111010-01005.
Odhiambo, J. A.; Williams HC; Clayton TO; Robertson CF; Asher MI (2009). „Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.”. The Journal of Allergy and Clinical Immunology. 124 (6): 1251—1258. PMID 20004783. doi:10.1016/j.jaci.2009.10.009. hdl:10757/625751.
Cork, M. J.; Danby SG; Vasilopoulos Y; Hadgraft J; Lane ME; et al. (2009). „Epidermal barrier dysfunction in atopic dermatitis”. The Journal of Investigative Dermatology. 129 (8): 1892—1908. PMID 19494826. doi:10.1038/jid.2009.133. .
Walling, H. W.; Swick, B. L. (2010). „Update on the management of chronic eczema: new approaches and emerging treatment options.”. Clin Cosmet Investig Dermatol. 3: 99—117. PMC 3047944 . PMID 21437065. doi:10.2147/CCID.S6496 . .

Odhiambo, J. A.; Williams HC; Clayton TO; Robertson CF; Asher MI (2009). „Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.”. The Journal of Allergy and Clinical Immunology. 124 (6): 1251—1258. PMID 20004783. doi:10.1016/j.jaci.2009.10.009. hdl:10757/625751.

Bershad, SV (1. 11. 2011). „In the clinic. Atopic dermatitis (eczema)”. Annals of Internal Medicine. 155 (9): ITC51—15; quiz ITC516. PMID 22041966. doi:10.7326/0003-4819-155-9-201111010-01005.
Odhiambo, J. A.; Williams HC; Clayton TO; Robertson CF; Asher MI (2009). „Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.”. The Journal of Allergy and Clinical Immunology. 124 (6): 1251—1258. PMID 20004783. doi:10.1016/j.jaci.2009.10.009. hdl:10757/625751.
De Benedetto A1, Agnihothri R, McGirt LY, Bankova LG, Beck LA. Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol. 2009
Cork, M. J.; Danby SG; Vasilopoulos Y; Hadgraft J; Lane ME; et al. (2009). „Epidermal barrier dysfunction in atopic dermatitis”. The Journal of Investigative Dermatology. 129 (8): 1892—1908. PMID 19494826. doi:10.1038/jid.2009.133. .
Walling, H. W.; Swick, B. L. (2010). „Update on the management of chronic eczema: new approaches and emerging treatment options.”. Clin Cosmet Investig Dermatol. 3: 99—117. PMC 3047944 . PMID 21437065. doi:10.2147/CCID.S6496 . .

Odhiambo, J. A.; Williams HC; Clayton TO; Robertson CF; Asher MI (2009). „Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.”. The Journal of Allergy and Clinical Immunology. 124 (6): 1251—1258. PMID 20004783. doi:10.1016/j.jaci.2009.10.009. hdl:10757/625751.